All Stories

  1. An update on emerging drugs in osteosarcoma: towards tailored therapies?

    Article • Expert Opinion on Emerging Drugs, August 2019, Taylor & Francis

    Claudia Hattinger

  2. Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment

    Article • Expert Opinion on Drug Metabolism & Toxicology, March 2019, Taylor & Francis

    Claudia Hattinger

  3. Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?

    Article • Expert Review of Molecular Diagnostics, October 2018, Taylor & Francis

    Claudia Hattinger

  4. Genome-wide association study identifies the GLDC /IL33 locus associated with survival of osteosarcoma patients

    Article • International Journal of Cancer, December 2017, Wiley

    Claudia Hattinger